U.S. Funding Biolabs in Ukraine, Documents Show
Anthrax was handled in at least one Ukrainian lab
If we are to believe Judicial Watch, an organization that promotes transparency, accountability and integrity in government, “the United States funded anthrax laboratory activities in a Ukrainian biolab.” Through the U.S. Freedom of Information Act (FOIA), Judicial Watch obtained a 345-page document from the Defense Threat Reduction Agency (DTRA), a component of the U.S. Department of Defense, which proves that the U.S. government contributed financially to at least one Ukrainian lab.
Despite dozens of pages of the DTRA document being completely or partially redacted, Judicial Watch discovered that the United States provided a little over $11 million in funding for Ukraine’s biological program. The document shows, among other things, that “anthrax laboratory activities were conducted on December 28, 2018.”
A Kansas City engineering firm, Black & Veatch, conducted training workshops and implemented a “pathogenic asset control” plan on-site.
A Conspiracy Theory That Wasn’t
Until March 2022, the presence of biological laboratories in Ukraine was viewed as a conspiracy theory. But the U.S. Under Secretary of State for Political Affairs, Victoria Nuland, was forced to admit that these facilities were not a figment of our imagination. Although Nuland denied that the labs produced biological and bacteriological weapons, she expressed concern that Russian forces would be seeking to gain control of them. Why?
The Director of the Information and Press Department of the Russian Ministry of Foreign Affairs, Maria Zakharova, offered the beginning of an answer by stating that Ukraine’s bacteriological program involved deadly pathogens. But U.S. officials, along with their media valets, branded Zakharova’s statement as a lie. Yet, the documents obtained by Judicial Watch confirmed the facts since anthrax is precisely considered a deadly pathogen.
President Biden’s Son Linked to Ukrainian Labs
The National Pulse reported in late March that Rosemont Seneca Technology Partners (RSTP), an investment firm co-founded by Hunter Biden, President Joe Biden’s son, was among the top financial backers of a pharmaceutical company that allegedly collaborated in the identification and isolation of deadly pathogens in Ukraine labs. The pharmaceutical company in question is the San Francisco-based Metabiota.
Rosemont Seneca Technology Partners (RSTP) received funding from the Department of Defense for this project during the Obama administration. One of Hunter Biden’s partners in this enterprise was Christopher Heinz, the stepson of former U.S. Secretary of State, John Kerry.
The National Pulse, referring to an annual report from the Science and Technology Center in Ukraine (STCU), mentioned that a “trilateral meeting” involving delegations from Ukraine, Poland and the United States took place in October 2016 on the topic of “Biological Safety, Security and Surveillance.” Among the attendees were representatives of Metabiota along with military officials from the United States and Ukraine.
Those delegations discussed “cooperation in surveillance and prevention of especially dangerous infectious diseases, including zoonotic diseases in Ukraine and neighboring countries.” The same annual report of the Science and Technology Center in Ukraine pointed out another meeting between representatives of Metabiota, Ukrainian scientists and U.S. Department of Defense officials.
A scientist, Artem Skrypnyk, is said to have collaborated with Metabiota in research projects on anthrax. Skrypnyk currently serves as a technical officer for the World Health Organization (WHO). Ironically, the WHO, according to Reuters, had advised Ukraine to destroy high-risk pathogens housed in the country’s public health laboratories in order to prevent the spread of diseases among the population.
Sources
Judicial Watch, Reuters, Reuters via CTV News, The National Pulse, Times Now
